Daniel Muñoz
banner
dfmunozp.bsky.social
Daniel Muñoz
@dfmunozp.bsky.social
PharmD, BCCCP
Clinical Pharmacy Specialist, ICU/PK
Base Valdivia Hospital, Valdivia, Chile
Reposted by Daniel Muñoz
EMCrit 413 - Translating Recent Sepsis Papers to the Bedside with @PulmCrit (Farkas)
- Confounding Effects of Vasopressin
- Perfusion Index?
- Echo-Pressor-Echo
& so much more...
[#FOAMed for now]
emcrit.org/413
EMCrit 413 - Translating Recent Sepsis Papers to the Bedside with PulmCrit (Farkas)
Ok, new sepsis papers, but what should we actually do?
emcrit.org
November 30, 2025 at 12:22 AM
Reposted by Daniel Muñoz
Trimethoprim-sulfamethoxazole carries a very low (but real) risk of causing ARDS.

Duration of therapy is a risk factor (>7 days).

Could likely be minimized by avoiding unnecessarily long courses.

TMP-SMX is usually well tolerated, but can wreak havok (SJS, ARDS, drug-induced meningitis). #EMIMCC
November 24, 2025 at 8:48 PM
Reposted by Daniel Muñoz
Patient with cirrhosis and INR of 3 needs a procedure

Please step away from the FFP

EVERY guideline & article agrees that FFP shouldn't be given for pre-procedure coag optimization (even high-risk procedures)

Plt & fibrinogen are more controversial

Discussion emcrit.org/ibcc/cirrhos... #EMIMCC
November 27, 2025 at 1:06 PM